MA51675A - Compositions pharmaceutiques pour le traitement de la douleur postopératoire - Google Patents

Compositions pharmaceutiques pour le traitement de la douleur postopératoire

Info

Publication number
MA51675A
MA51675A MA051675A MA51675A MA51675A MA 51675 A MA51675 A MA 51675A MA 051675 A MA051675 A MA 051675A MA 51675 A MA51675 A MA 51675A MA 51675 A MA51675 A MA 51675A
Authority
MA
Morocco
Prior art keywords
treatment
pharmaceutical compositions
postoperative pain
postoperative
pain
Prior art date
Application number
MA051675A
Other languages
English (en)
Other versions
MA51675B1 (fr
Inventor
Fabio Bettella
Devis Galesso
Andrea Pastorello
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of MA51675A publication Critical patent/MA51675A/fr
Publication of MA51675B1 publication Critical patent/MA51675B1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
MA51675A 2018-01-25 2019-01-23 Compositions pharmaceutiques pour le traitement de la douleur postopératoire MA51675B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT201800001890A IT201800001890A1 (it) 2018-01-25 2018-01-25 Composizioni farmaceutiche per il trattamento del dolore postoperatorio
PCT/IB2019/050552 WO2019145863A1 (fr) 2018-01-25 2019-01-23 Compositions pharmaceutiques pour le traitement de la douleur postopératoire
EP19705572.6A EP3743043B1 (fr) 2018-01-25 2019-01-23 Compositions pharmaceutiques pour le traitement de la douleur postopératoire

Publications (2)

Publication Number Publication Date
MA51675A true MA51675A (fr) 2021-04-28
MA51675B1 MA51675B1 (fr) 2024-09-30

Family

ID=62089870

Family Applications (1)

Application Number Title Priority Date Filing Date
MA51675A MA51675B1 (fr) 2018-01-25 2019-01-23 Compositions pharmaceutiques pour le traitement de la douleur postopératoire

Country Status (17)

Country Link
US (1) US11357858B2 (fr)
EP (1) EP3743043B1 (fr)
KR (1) KR102819336B1 (fr)
CN (1) CN111629713B (fr)
AU (1) AU2019212448B2 (fr)
CA (1) CA3086650A1 (fr)
DK (1) DK3743043T3 (fr)
EA (1) EA202091613A1 (fr)
ES (1) ES2987059T3 (fr)
FI (1) FI3743043T3 (fr)
IT (1) IT201800001890A1 (fr)
LT (1) LT3743043T (fr)
MA (1) MA51675B1 (fr)
PL (1) PL3743043T3 (fr)
PT (1) PT3743043T (fr)
SA (1) SA520412416B1 (fr)
WO (1) WO2019145863A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4192436A4 (fr) * 2020-08-10 2024-10-02 Ziropa, Inc. Compositions et procédés d'administration topique
JP2024519426A (ja) * 2020-09-29 2024-05-14 ジロパ・インコーポレイテッド 疼痛の緩和及び麻痺のための組成物及び方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
AU7244696A (en) * 1995-09-29 1997-04-17 Lam Pharmaceuticals Inc. Sustained release delivery system and long acting narcotic analgesics and antagonists
IT1287967B1 (it) * 1996-10-17 1998-09-10 Fidia Spa In Amministrazione S Preparazioni farmaceutiche per uso anestetico locale
ITPD980169A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US20040001889A1 (en) * 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US8846068B2 (en) * 2008-04-18 2014-09-30 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising a local anesthetic
US8357795B2 (en) * 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
IT1401498B1 (it) * 2010-07-30 2013-07-26 Mero Srl Idrogelo a base di acido ialuronico e suo uso in ortopedia
EP2484387A1 (fr) * 2011-02-03 2012-08-08 Q-Med AB Composition d'acide hyaluronique
LT3049055T (lt) * 2013-09-27 2018-07-25 Anteis S.A. Injekcinio hidrogelio, sterilizuoto karščiu, sudaryto iš hialurono rūgšties, turinčio miltelių pavidalo lidokaino ir šarminio agento, gamybos būdas

Also Published As

Publication number Publication date
ES2987059T3 (es) 2024-11-13
CA3086650A1 (fr) 2019-08-01
EA202091613A1 (ru) 2020-10-15
PT3743043T (pt) 2024-09-19
DK3743043T3 (da) 2024-09-02
US20200360519A1 (en) 2020-11-19
LT3743043T (lt) 2024-10-25
SA520412416B1 (ar) 2023-02-12
KR20200113239A (ko) 2020-10-06
IT201800001890A1 (it) 2019-07-25
KR102819336B1 (ko) 2025-06-11
AU2019212448B2 (en) 2024-08-15
WO2019145863A1 (fr) 2019-08-01
EP3743043A1 (fr) 2020-12-02
MA51675B1 (fr) 2024-09-30
CN111629713A (zh) 2020-09-04
EP3743043B1 (fr) 2024-07-24
CN111629713B (zh) 2024-03-19
AU2019212448A1 (en) 2020-07-09
PL3743043T3 (pl) 2024-11-25
US11357858B2 (en) 2022-06-14
FI3743043T3 (fi) 2024-10-25

Similar Documents

Publication Publication Date Title
MA51739A (fr) Compositions pharmaceutiques pour le traitement de la fibrose kystique
MA51200A (fr) Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies
EP3431105A4 (fr) Composition médicinale pour le traitement du cancer
EP3426258A4 (fr) Compositions d'antibiotiques stéroïdiens cationiques pour le traitement de tissu dermique
MA52873A (fr) Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies
EP3704108A4 (fr) Composés et compositions pour le traitement de troubles hématologiques
MA50391A (fr) Nouveaux composés et compositions pharmaceutiques associées pour le traitement de troubles inflammatoires
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
EP3946357A4 (fr) Formulations topiques pour le traitement de neuropathies périphériques
EP3766497A4 (fr) Médicament pour le traitement de la toux
MA55218A (fr) Eskétamine pour le traitement de la dépression
EP3898991A4 (fr) Administration périnéale de résinifératoxine pour le traitement de la douleur maladaptative
EP3716966A4 (fr) Compositions d'alpha-cétoacides pour le traitement de l'hypoalbuminémie
MA51738A (fr) Composés pour le traitement de la douleur
PL3424499T3 (pl) Kompozycja farmaceutyczna do leczenia bólu neuropatycznego
MA46086A (fr) Schéma posologique pour le traitement de tumeurs solides
EP3801478A4 (fr) Méthodes et compositions pour la prévention ou le traitement de la calciphylaxie
EP3518918A4 (fr) Méthodes et compositions pharmaceutiques pour le traitement de la stéatohépatite non alcoolique
MA55982A (fr) Composition pharmaceutique pour le traitement de tumeurs
EP3533451A4 (fr) Application de paeéniflorin-6'-o-benzène sulfonate en médecine pour le traitement du syndrome de sjögren
EP3533471A4 (fr) Composition pour le soulagement ou le traitement de la douleur
MA55752A (fr) Nouveaux composés et compositions pharmaceutiques associées pour le traitement de néphropathies
MA51675A (fr) Compositions pharmaceutiques pour le traitement de la douleur postopératoire
EP3354284A4 (fr) Composition pour le traitement de la douleur
EP3858351A4 (fr) Composition pharmaceutique pour le traitement de la fibrose